Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 1/2017

01-03-2017

Hyponatremia and bone disease

Authors: Armando Luis Negri, Juan Carlos Ayus

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 1/2017

Login to get access

Abstract

Hip fractures represent a serious health risk in the elderly, causing substantial morbidity and mortality. There is now a considerable volume of literature suggesting that chronic hyponatremia increases the adjusted odds ratio (OR) for both falls and fractures in the elderly. Hyponatremia appears to contribute to falls and fractures by two mechanisms. First, it produces mild cognitive impairment, resulting in unsteady gait and falls; this is probably due to the loss of glutamate (a neurotransmitter involved in gait function) as an osmolyte during brain adaptation to chronic hyponatremia. Second, hyponatremia directly contributes to osteoporosis and increased bone fragility by inducing increased bone resorption to mobilize sodium stores in bone. Low extracellular sodium directly stimulates osteoclastogenesis and bone resorptive activity through decreased cellular uptake of ascorbic acid and the induction of oxidative stress; these effects occur in a sodium level-dependent manner. Hyponatremic patients have elevated circulating arginine-vasopressin (AVP) levels, and AVP acting on two receptors expressed in osteoblasts and osteoclasts, Avpr1α and Avpr2, can increase bone resorption and decrease osteoblastogenesis. Should we be screening for low serum sodium in patients with osteoporosis or assessing bone mineral density (BMD) in patients with hyponatremia? The answers to these questions have not been established. Definitive answers will require randomized controlled studies that allocate elderly individuals with mild hyponatremia to receive either active treatment or no treatment for hyponatremia, to determine whether correction of hyponatremia prevents gait disturbances and changes in BMD, thereby reducing the risk of fractures. Until such studies are conducted, physicians caring for elderly patients must be aware of the association between hyponatremia and bone disorders. As serum sodium is a readily available, simple, and affordable biochemical measurement, clinicians should look for hyponatremia in elderly patients, especially in those receiving medications that can cause hyponatremia. Furthermore, elderly patients with an unsteady gait and/or confusion should be evaluated for the presence of mild hyponatremia, and if present, treatment should be initiated. Finally, elderly patients presenting with an orthopedic injury should have serum sodium checked and hyponatremia corrected, if present.
Literature
1.
go back to reference Moritz ML, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant. 2003;18:2486–91. Moritz ML, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant. 2003;18:2486–91.
2.
go back to reference Ayus JC, Achinger SG, Arief A. Brain cell volume regulation in hyponatremia: Role of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol. 2008;295:F619–24. Ayus JC, Achinger SG, Arief A. Brain cell volume regulation in hyponatremia: Role of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol. 2008;295:F619–24.
3.
go back to reference Ayus JC, Wheeler JM, Arief AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117:891–7. Ayus JC, Wheeler JM, Arief AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117:891–7.
4.
go back to reference Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy: non-cardiogenic pulmonary edema and hypercapnic respiratory failure. Chest. 1995;107:517–22. Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy: non-cardiogenic pulmonary edema and hypercapnic respiratory failure. Chest. 1995;107:517–22.
5.
go back to reference Ayus JC, Varon J, Arieff AI. Hyponatremia, Cerebral edema, and non-cardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–4. Ayus JC, Varon J, Arieff AI. Hyponatremia, Cerebral edema, and non-cardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–4.
6.
go back to reference Kalantar-Zadeh K, Nuguyen MK, Chang R, Kurtz I. Fatal hyponatremia in a young woman after ecstasy ingestion. Nat Clin Pract Nephrol. 2006;2:283–8. Kalantar-Zadeh K, Nuguyen MK, Chang R, Kurtz I. Fatal hyponatremia in a young woman after ecstasy ingestion. Nat Clin Pract Nephrol. 2006;2:283–8.
7.
go back to reference Porto Carreiro F, Christmas C. Hip Fracture Ann Inter Med. 2011;155:ITC6–1. Porto Carreiro F, Christmas C. Hip Fracture Ann Inter Med. 2011;155:ITC6–1.
8.
go back to reference Ayus JC, Arieff AI. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA. 1999;281:2299–304. Ayus JC, Arieff AI. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA. 1999;281:2299–304.
9.
go back to reference Spasovsky G, Vanholder R, Allolio B et al. Clinical practice guideline on diagnosis and treatment of hyponatremia. Eur J Endocrinol. 2014;170:G1–47. Spasovsky G, Vanholder R, Allolio B et al. Clinical practice guideline on diagnosis and treatment of hyponatremia. Eur J Endocrinol. 2014;170:G1–47.
10.
go back to reference Mohan S, Gu S, Parikh A et al. Prevalence of Hyponatremia and association with mortality: results from NAHANES. Am J Med. 2013;126:1127–37. Mohan S, Gu S, Parikh A et al. Prevalence of Hyponatremia and association with mortality: results from NAHANES. Am J Med. 2013;126:1127–37.
11.
go back to reference Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. J Am Geriatr Soc. 2006;54:345–53. Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. J Am Geriatr Soc. 2006;54:345–53.
12.
go back to reference Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995;43:1410–3. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995;43:1410–3.
13.
go back to reference Bigaillon C, El Jahiri Y, Garcia C, Hejl-Garcia C, Mayaudon H, Ceppa F, Burnat P. Inappropriate ADH secretion-induced hyponatremia associated with paroxetine use. Rev Med Interne. 2007;28:642–4. Bigaillon C, El Jahiri Y, Garcia C, Hejl-Garcia C, Mayaudon H, Ceppa F, Burnat P. Inappropriate ADH secretion-induced hyponatremia associated with paroxetine use. Rev Med Interne. 2007;28:642–4.
14.
go back to reference Nirmalani A, Stock SL, Catalano G. Syndrome of inappropriate antidiuretic hormone associated with escitalopram therapy. CNS Spect. 2006;11:429–32. Nirmalani A, Stock SL, Catalano G. Syndrome of inappropriate antidiuretic hormone associated with escitalopram therapy. CNS Spect. 2006;11:429–32.
15.
go back to reference Fonzo-Christe C, Vogt N. Susceptibility of the elderly patient to hyponatremia induced by selective serotonin reuptake inhibitors. Therapie. 2000;55:597–604. Fonzo-Christe C, Vogt N. Susceptibility of the elderly patient to hyponatremia induced by selective serotonin reuptake inhibitors. Therapie. 2000;55:597–604.
16.
go back to reference Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009;361:2153–64. Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med. 2009;361:2153–64.
17.
go back to reference Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139:476–82. Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139:476–82.
18.
go back to reference Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101:583–8. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101:583–8.
19.
go back to reference Sandhu HS, Gilles E, DeVita MV, Panagopoulos G, Michelis MF. Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol. 2009;41:733–7. Sandhu HS, Gilles E, DeVita MV, Panagopoulos G, Michelis MF. Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol. 2009;41:733–7.
20.
go back to reference Tolouian R, Alhamad T, Farazmand, Mulla ZD. The correlation of hip fracture and hyponatremia in the elderly. J Nephrol. 2012;25(5):789–93. Tolouian R, Alhamad T, Farazmand, Mulla ZD. The correlation of hip fracture and hyponatremia in the elderly. J Nephrol. 2012;25(5):789–93.
21.
go back to reference McPherson E, Dunsmuir RA. Hyponatraemia in hip fracture patients. Scott Med J. 2002;47:115–6. McPherson E, Dunsmuir RA. Hyponatraemia in hip fracture patients. Scott Med J. 2002;47:115–6.
22.
go back to reference Kinsella S, Moran S, Sullivan MO, Molloy MG, Eustace JA. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010;5:275–80. Kinsella S, Moran S, Sullivan MO, Molloy MG, Eustace JA. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010;5:275–80.
23.
go back to reference Hoorn EJ, Rivadeneira F, van Meurs JB, et al. Mild hyponatremia as a risk factor for fractures: The Rotterdam Study. J Bone Miner Res. 2011;26:1822–8. Hoorn EJ, Rivadeneira F, van Meurs JB, et al. Mild hyponatremia as a risk factor for fractures: The Rotterdam Study. J Bone Miner Res. 2011;26:1822–8.
24.
go back to reference Lu-Yao GL, Baron JA, Barrett JA, Fisher ES. Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health. 1994;84(8):1287–91. Lu-Yao GL, Baron JA, Barrett JA, Fisher ES. Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health. 1994;84(8):1287–91.
25.
go back to reference Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380–90. Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152(6):380–90.
26.
go back to reference Jamal SA, Arampatzis S, Harrison SL, Bucur RC, Ensrud K, Orwoll ES, Bauer DC. Hyponatremia and Fractures: Findings From the MrOS Study. J Bone Miner Res. 2015;30(6):970–5. Jamal SA, Arampatzis S, Harrison SL, Bucur RC, Ensrud K, Orwoll ES, Bauer DC. Hyponatremia and Fractures: Findings From the MrOS Study. J Bone Miner Res. 2015;30(6):970–5.
27.
go back to reference Ayus JC, Fuentes NA, Negri AL et al. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016. pii:gfw029. Ayus JC, Fuentes NA, Negri AL et al. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016. pii:gfw029.
28.
go back to reference Rachner TD, Kosla D, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377:1276–87. Rachner TD, Kosla D, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377:1276–87.
29.
go back to reference Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA. Resnick HE Hyponatremia induced osteoporosis. J Bone Miner Res. 2010;25:554–63. Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA. Resnick HE Hyponatremia induced osteoporosis. J Bone Miner Res. 2010;25:554–63.
30.
go back to reference Kruse C, Eiken P, Verbalis J, Vestergaard P. Hyponatremia and osteoporosis: insights from the Danish National Patient Registry. Osteoporos Int. 2015;26(3):1005–16. Kruse C, Eiken P, Verbalis J, Vestergaard P. Hyponatremia and osteoporosis: insights from the Danish National Patient Registry. Osteoporos Int. 2015;26(3):1005–16.
31.
go back to reference Afshinnia F, Sundaram B, Ackermann RJ, Wong KK. Hyponatremia and osteoporosis: reappraisal of a novel association. Osteoporos Int. 2015;26(9):2291–8. Afshinnia F, Sundaram B, Ackermann RJ, Wong KK. Hyponatremia and osteoporosis: reappraisal of a novel association. Osteoporos Int. 2015;26(9):2291–8.
32.
go back to reference Holm JP, Amar AO, Hyldstrup L, Jensen JE. Hyponatremia, a risk factor for osteoporosis and fractures in women. Osteoporos Int. 2016;27(3):989–1001. Holm JP, Amar AO, Hyldstrup L, Jensen JE. Hyponatremia, a risk factor for osteoporosis and fractures in women. Osteoporos Int. 2016;27(3):989–1001.
33.
go back to reference Lawson AE, Fazeli PK, Calder G et al. Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: A cross sectional study. J Clin Psychiatry. 2012;73:e1379–31383. Lawson AE, Fazeli PK, Calder G et al. Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: A cross sectional study. J Clin Psychiatry. 2012;73:e1379–31383.
34.
go back to reference Levy-Shraga Y, David D, Vered I, Kochavi B, Stein D, Modan-Moses D. Hyponatremia and decreased bone density in adolescent inpatients diagnosed with anorexia nervosa. Nutrition. 2016;32(10):1097–102. Levy-Shraga Y, David D, Vered I, Kochavi B, Stein D, Modan-Moses D. Hyponatremia and decreased bone density in adolescent inpatients diagnosed with anorexia nervosa. Nutrition. 2016;32(10):1097–102.
35.
go back to reference Verghese J, Levalley A, Hall CB, Katz MJ, Ambrose AF, Lipton RB. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc. 2006;54:255–61. Verghese J, Levalley A, Hall CB, Katz MJ, Ambrose AF, Lipton RB. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc. 2006;54:255–61.
36.
go back to reference Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119:71.e1–8. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119:71.e1–8.
37.
go back to reference Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–112. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–112.
38.
go back to reference Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest. 1991;88(1):303–9. Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest. 1991;88(1):303–9.
39.
go back to reference Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res. 1991;567(2):274–82. Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res. 1991;567(2):274–82.
40.
go back to reference Yuen EY, Liu W, Karatsoreos IN, Feng J, McEwen BS, Yan Z. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc Natl Acad Sci U S A. 2009;106(33):14075–9. Yuen EY, Liu W, Karatsoreos IN, Feng J, McEwen BS, Yan Z. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc Natl Acad Sci U S A. 2009;106(33):14075–9.
41.
go back to reference Fujisawa H, Sugimura Y, Takagi H, Mizoguchi H, Takeuchi H, Izumida H, Nakashima K, Ochiai H, Takeuchi S, Kiyota A, Fukumoto K, Iwama S, Takagishi Y, Hayashi Y, Arima H, Komatsu Y, Murata Y, Oiso Y. Chronic hyponatremia causes neurologic and psychologic impairments. J Am Soc Nephrol. 2016;27(3):766–80. Fujisawa H, Sugimura Y, Takagi H, Mizoguchi H, Takeuchi H, Izumida H, Nakashima K, Ochiai H, Takeuchi S, Kiyota A, Fukumoto K, Iwama S, Takagishi Y, Hayashi Y, Arima H, Komatsu Y, Murata Y, Oiso Y. Chronic hyponatremia causes neurologic and psychologic impairments. J Am Soc Nephrol. 2016;27(3):766–80.
42.
go back to reference Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330(9):613–22. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330(9):613–22.
43.
go back to reference Miyazaki T, Ohmoto K, Hirose T, Fujiki H. Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan. J Endocrinol. 2010;206:105–20. Miyazaki T, Ohmoto K, Hirose T, Fujiki H. Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan. J Endocrinol. 2010;206:105–20.
44.
go back to reference Basony J, Sugimuar Y, Verbalisa JG. Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-inducerd bone loss. J Biol Chem. 2011;286:10864–75. Basony J, Sugimuar Y, Verbalisa JG. Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-inducerd bone loss. J Biol Chem. 2011;286:10864–75.
45.
go back to reference Bergstrom WH, Wallace WM. Bone as a sodium and potassium reservoir. J Clin Invest. 1954;33:867–73. Bergstrom WH, Wallace WM. Bone as a sodium and potassium reservoir. J Clin Invest. 1954;33:867–73.
46.
go back to reference Bergstrom WH. The participation of bone in total body sodium metabolism in the rat. J Clin Invest. 1955;34:97–1004. Bergstrom WH. The participation of bone in total body sodium metabolism in the rat. J Clin Invest. 1955;34:97–1004.
47.
go back to reference Usala RL, Fernandez SJ, Mete M, Cowen L, Shara NM, Barsony J, Verbalis JG. Hyponatremia is associated with increased osteoporosis and bone fractures in a large US health system population. J Clin Endocrinol Metab. 2015;100(8):3021–31. Usala RL, Fernandez SJ, Mete M, Cowen L, Shara NM, Barsony J, Verbalis JG. Hyponatremia is associated with increased osteoporosis and bone fractures in a large US health system population. J Clin Endocrinol Metab. 2015;100(8):3021–31.
48.
go back to reference Tamma R, Sun L, Cuscito C, Lu P, Corcelli M, Li J, Colaianni G, Moonga SS, Di Benedetto A, Grano M, Colucci S, Yuen T, New MI, Zallone A, Zaidi M. Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci U S A. 2013;110(46):18644–9. Tamma R, Sun L, Cuscito C, Lu P, Corcelli M, Li J, Colaianni G, Moonga SS, Di Benedetto A, Grano M, Colucci S, Yuen T, New MI, Zallone A, Zaidi M. Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci U S A. 2013;110(46):18644–9.
49.
go back to reference Sun L, Tamma R, Yuen T, Colaianni G, Ji Y, Cuscito C, Bailey J, Dhawan S, Lu P, Calvano CD, Zhu LL, Zambonin CG, Di Benedetto A, Stachnik A, Liu P, Grano M, Colucci S, Davies TF, New MI, Zallone A, Zaidi M. Functions of vasopressin and oxytocin in bone mass regulation. Proc Natl Acad Sci U S A. 2016;113(1):164–9. Sun L, Tamma R, Yuen T, Colaianni G, Ji Y, Cuscito C, Bailey J, Dhawan S, Lu P, Calvano CD, Zhu LL, Zambonin CG, Di Benedetto A, Stachnik A, Liu P, Grano M, Colucci S, Davies TF, New MI, Zallone A, Zaidi M. Functions of vasopressin and oxytocin in bone mass regulation. Proc Natl Acad Sci U S A. 2016;113(1):164–9.
50.
go back to reference Morgenthaler NG, Struck J, Jochberger S, Dunser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab. 2008;19:43–9. Morgenthaler NG, Struck J, Jochberger S, Dunser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab. 2008;19:43–9.
51.
go back to reference Balanescu S, Kopp P, Gaskill MB, et al. Correlation of plasma copeptin andvasopressin concentrations in hypo-, iso-, and hyperosmolar states. J Clin Endocrinol Metab. 2011;96:1046–52. Balanescu S, Kopp P, Gaskill MB, et al. Correlation of plasma copeptin andvasopressin concentrations in hypo-, iso-, and hyperosmolar states. J Clin Endocrinol Metab. 2011;96:1046–52.
52.
go back to reference Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS. Investigation of the Neurocognitive Impact of Sodium Improvement in Geriatric Hyponatremia: Efficacy and Safety of Tolvaptan (INSIGHT) Investigators. Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT). Am J Kidney Dis. 2016 Feb 10. pii: S0272-6386(16)00015-9. Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS. Investigation of the Neurocognitive Impact of Sodium Improvement in Geriatric Hyponatremia: Efficacy and Safety of Tolvaptan (INSIGHT) Investigators. Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT). Am J Kidney Dis. 2016 Feb 10. pii: S0272-6386(16)00015-9.
53.
go back to reference Sejling AS, Thorsteinsson AL, Pedersen-Bjergaard U, Eiken P. Recovery from SIADH-associated osteoporosis: a case report. J Clin Endocrinol Metab. 2014;99(10):3527–30. Sejling AS, Thorsteinsson AL, Pedersen-Bjergaard U, Eiken P. Recovery from SIADH-associated osteoporosis: a case report. J Clin Endocrinol Metab. 2014;99(10):3527–30.
54.
go back to reference Rudge JE, Kim D. New-onset hyponatremia after surgery for traumatic hip fracture. Age Ageing. 2014;43(6):821–6. Rudge JE, Kim D. New-onset hyponatremia after surgery for traumatic hip fracture. Age Ageing. 2014;43(6):821–6.
Metadata
Title
Hyponatremia and bone disease
Authors
Armando Luis Negri
Juan Carlos Ayus
Publication date
01-03-2017
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 1/2017
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9387-7

Other articles of this Issue 1/2017

Reviews in Endocrine and Metabolic Disorders 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.